113 related articles for article (PubMed ID: 9061698)
1. 99Tcm-dimercaptopropionyl-HSA prepared from a labelling kit: preliminary investigations as a blood pool agent.
Cambier JP; Verbeke KA; Vanbilloen HP; Bormans GM; de Roo MJ; Verbruggen AM
Nucl Med Commun; 1997 Jan; 18(1):31-7. PubMed ID: 9061698
[TBL] [Abstract][Full Text] [Related]
2. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
[TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma volume using 99Tc(m)-labelled DMP-HSA.
du Raan H; Lötter MG; Harris GW; van Aswegen A; Otto AC; Nel MG; Badenhorst PN; Verbeke KA; Verbruggen AM
Nucl Med Commun; 2000 Jun; 21(6):539-44. PubMed ID: 10894563
[TBL] [Abstract][Full Text] [Related]
4. First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer.
Verbeke KA; Vanhecke WB; Mortelmans LA; Verbruggen AM
Eur J Nucl Med; 1994 Sep; 21(9):906-12. PubMed ID: 7995283
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agents.
Verbeke K; Hjelstuen O; Debrock E; Cleynhens B; De Roo M; Verbruggen A
Nucl Med Commun; 1995 Nov; 16(11):942-57. PubMed ID: 8587761
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a kit formulation for the preparation of 99mTc-DMP-HSA, a new tracer agent for radionuclide ventriculography.
Verbeke KA; Schiepers CW; Wyndaele DN; Baetens JA; Verbeke GN; De Roo MJ; Verbruggen AM
Nucl Med Biol; 1997 Aug; 24(6):571-8. PubMed ID: 9316087
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.
Verbeke KA; Vanbilloen HP; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Jun; 20(6):473-82. PubMed ID: 8339730
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-p-aminohippuric acid as a new renal agent.
Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and absorbed radiation dose estimates of 99mTc-labeled dimercaptopropionyl human serum albumin.
van Aswegen A; Marais J; Kemp G; Nel MG; van Staden JA; Otto AC; Lötter MG; Verbruggen AM
J Nucl Med; 1999 Sep; 40(9):1532-5. PubMed ID: 10492376
[TBL] [Abstract][Full Text] [Related]
10. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kits.
Vanbilloen HP; Verbeke KA; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Jun; 20(6):465-72. PubMed ID: 8339729
[TBL] [Abstract][Full Text] [Related]
12. A kit for the instant preparation of 99Tcm-citrate for tumour and inflammation scintigraphy.
Chauhan UP; Mishra P; Chuttani K; Bhatnagar A; Bal CS
Nucl Med Commun; 1996 Nov; 17(11):979-85. PubMed ID: 8971871
[TBL] [Abstract][Full Text] [Related]
13. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphic diagnosis of gastrointestinal bleeding with 99Tcm-dextran.
Bhatnagar A; Singh AK; Lahoti D; Singh T; Chakravarty SK; Rawat H; Chauhan UP; Mondal A
Nucl Med Commun; 1996 Oct; 17(10):834-8. PubMed ID: 8951902
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm-MAG3: in vitro stability and in vivo behaviour at different times after preparation.
Millar AM; Wilkinson AG; McAteer E; Best JJ
Nucl Med Commun; 1990 Jun; 11(6):405-12. PubMed ID: 2143569
[TBL] [Abstract][Full Text] [Related]
16. A new stannous agent kit for labelling red blood cells with 99TCM and its clinical application.
Ducassou D; Arnaud D; Bardy A; Beydon J; Baquey C
Br J Radiol; 1976 Apr; 49(580):344-7. PubMed ID: 181112
[TBL] [Abstract][Full Text] [Related]
17. Labelling of poly-L-lysine with 99mTc and evaluation as a possible tracer agent for ventriculography.
Verbeke K; Ons S; De Roo M; Verbruggen A
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):75-8. PubMed ID: 7632772
[TBL] [Abstract][Full Text] [Related]
18. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
Pauwels EK; Feitsma RI
Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of six kits of technetium 99m human serum albumin injection for cardiac blood pool imaging.
Millar AM; Hannan WJ; Sapru RP; Muir AL
Eur J Nucl Med; 1979 Apr; 4(2):91-4. PubMed ID: 499236
[TBL] [Abstract][Full Text] [Related]
20. In vivo stability of in vitro labelled 99Tcm-red blood cells for radionuclide determination of left ventricular ejection fractions and volumes.
Kelbaek H; Gjørup T; Fogh J
Nucl Med Commun; 1986 Jul; 7(7):541-7. PubMed ID: 3774253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
